Radiopharmaceuticals for the Visualization of Infectious and Inflammatory Lesions

Ercan, Meral Tayan; Kostakoglu, Lale
July 2000
Current Pharmaceutical Design;Jul2000, Vol. 6 Issue 11, p1159
Academic Journal
Many radiopharmaceuticals have been introduced for the scintigraphic demonstration of infectious and inflammatory lesions and some of them are currently in clinical use. They can be classified into two major categories according to their specificity. Specific radiopharmaceuticals include in vitro labeled leukocytes, radio-labelled monoclonal antibodies, and receptor specific small proteins and peptides. Nonspecific radiopharmaceuticals include radiolabelled nanocolloids, liposomes, macromolecules such as human immunoglobulin, dextran and human serum albumin, various small molecules and ions. In this review article radiopharmaceuticals in their respective groups are discussed as to the efficacy, and other parameters such as the physical characteristics of the radionuclides used, radiochemistry involved, availability, cost and biodistribution, emphasizing recent developments.


Related Articles

  • Radiolabelled Peptides and Monoclonal Antibodies for Therapy Decision Making in Inflammatory Diseases. Malviya, G.; Signore, A.; Laganà, B.; Dierckx, R. A. // Current Pharmaceutical Design;Aug2008, Vol. 14 Issue 24, p2401 

    Radiolabelled peptides and monoclonal antibodies are an emerging class of radiopharmaceuticals for imaging inflammation with clinical implications for several chronic inflammatory disorders for diagnosis, therapy decision making and follow up. In the last decades, a number of novel monoclonal...

  • Radionuclides and radiopharmaceuticals for single-photon emission tomography, positron emission tomography and radiotherapy in Russia. Krasikova, Raisa N.; Kodina, Galina E. // European Journal of Nuclear Medicine;1999, Vol. 26 Issue 7, p774 

    The current status of the manufacture of radiopharmaceuticals for diagnostic and therapeutic application in Russia is discussed, consideration being given to various aspects of the production and distribution of radionuclides, radioisotope generators and kits as well as individual...

  • Metaiodobenzylguanidine scintigraphy of the heart: what have we learnt clinically? Hattori, Naoya; Schwaiger, Markus // European Journal of Nuclear Medicine;2000, Vol. 27 Issue 1, p1 

    Editorial. Discusses the metaiodobenzylguanadine scintigraphy of the heart (MIBG). Requirements radiopharmaceutical must fulfill to become clinically useful; Myocardial kinetics of MIBG.

  • VirRAD – a "virtual" radiopharmacy learning community: your input needed. Mather, J // European Journal of Nuclear Medicine & Molecular Imaging;2002, Vol. 29 Issue 9, p1107 

    Focuses on the virtual radiopharmacy (VirRAD), a project which seeks to explore ways to foster an on-line radiopharmacy community in an attempt to improve communication and learning within the specialty. Total budget of the project; Remit provided by the research program; Concept for the VirRAD...

  • Reply. Kvinnsland, Yngve; Bruland, Øyvind; Moe, Lars; Skretting, Arne // European Journal of Nuclear Medicine & Molecular Imaging;2002, Vol. 29 Issue 10, p1415 

    Replies to comments by Lass and Scheffler to the authors' study 'A Method for measurement of the uptake patterns of two beta-emitting radionuclides in the same tissue section with a digital silicon detector: application to a study of [sup 89] SrCl[sub 2] and [sup 153] Sm-EDTMP in a dog with...

  • [sup 153] Sm-EDTMP and [sup 89] SrCl[sub 2] in a dog with spontaneous osteosarcoma. Lass, P.; Scheffler, J. // European Journal of Nuclear Medicine & Molecular Imaging;2002, Vol. 29 Issue 10, p1414 

    Comments on the study by Kvinnsland and others entitled 'A Method for measurement of the uptake patterns of two beta-emitting radionuclides in the same tissue section with a digital silicon detector: application to a study of [sup 89] SrCl[sub 2] and [sup 153] Sm-EDTMP in a dog with spontaneous...

  • Use of Technegas as a radiopharmaceutical for the measurement of gastric emptying. Kwiatek, Monika A.; Jones, Karen L.; Burch, William M.; Horowitz, Michael; Bartholomeusz, F. Dylan L. // European Journal of Nuclear Medicine;1999, Vol. 26 Issue 8, p903 

    Abstract. Many radiopharmaceuticals and test meals that are used to measure gastric emptying are less than optimal. A vegetable-based solid meal, such as rice, labelled with a radiopharmaceutical that also has the capacity to measure gastric emptying of liquids, is likely to be ideal. The role...

  • Study on the preparation and biological evaluation of Tc-gatifloxacin and Tc-cefepime complexes. Motaleb, M.; El-Kolaly, M.; Ibrahim, A.; Abd El-Bary, A. // Journal of Radioanalytical & Nuclear Chemistry;Jul2011, Vol. 289 Issue 1, p57 

    The aim of this work is the development of new radiopharmaceuticals for imaging infection and inflammation in human. Gatifloxacin (fluoroquinolone derivative) and cefepime (cephalosporine derivative) are antibiotics used to treat bacterial infections were investigated to label with one of the...

  • Folate Based Radiopharmaceuticals for Imaging and Therapy of Cancer and Inflammation. Müller, Cristina // Current Pharmaceutical Design;3/11/2012, Vol. 18 Issue 8, p1058 

    Frequent overexpression of the folate receptor (FR) on a variety of tumor types and on activated macrophages makes this receptor an interesting target for both imaging and therapy of cancer and inflammation. The FR is a glycosylphophatidylinositol-anchored protein that binds the vitamin folic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics